Skip to content

Bruno Mégarbane

4 papers in the library · 130 citations · publishing 2010-2025

Papers

Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).

The international journal of neuropsychopharmacology August 1, 2010 Nicolas Tournier, Lucie Chevillard, Bruno Mégarbane et al. 122 citations

Several drugs used in addiction treatment and substances of abuse inhibit the efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in vitro, which could alter their distribution in the body, including across the blood-brain barrier. Norbuprenorphine, buprenorphine, methadone, ibogaine, and THC inhibited P-gp in a concentration-dependent manner, with norbuprenorphine being the strongest. Buprenorphine, norbuprenorphine, ibogaine, and THC inhibited BCRP. Cocaine, amphetamine, nicotine, morphine, and others did not inhibit either transporter. Norbuprenorphine and methadone were transported by P-gp, but no tested compounds were transported by BCRP. The clinical relevance of norbuprenorphine's interaction with P-gp remains unclear.

A combined toxicokinetic and metabolic approach to investigate deschloro-N-ethylketamine exposure in a multidrug user.

Journal of pharmaceutical and biomedical analysis June 15, 2024 Romain Magny, Bruno Mégarbane, Lucie Chevillard et al. 7 citations

A chronic user of GHB, 3-MMC, and methoxetamine lost consciousness during a chemsex session and was admitted to intensive care, recovering quickly. Analysis of ten plasma samples over 29.5 hours, plus urine, hair, and a seized crystal, using liquid and gas chromatography, mass spectrometry, and nuclear magnetic resonance, confirmed exposure to multiple drugs including GHB, two benzofurans, two cathinones, and a new psychoactive substance: deschloro-N-ethyl-ketamine (O-PCE), an arylcyclohexylamine. Molecular networking identified 27 O-PCE metabolites, some previously unreported. O-PCE had an elimination half-life of about 5 hours. Lipid metabolism was markedly altered, likely from polydrug use.

Differences in the clinical presentation of acute 3,4-methylenedioxymetamfetamine intoxication by co-intoxication and patient sex to European emergency departments.

Clinical toxicology (Philadelphia, Pa.) March 1, 2025 Joep J. J. Ouwerkerk, David M. Wood, Alison M. Dines et al. 1 citation

When 3,4-methylenedioxymetamfetamine (MDMA) is taken with alcohol, emergency department visits show higher odds of agitation, drowsiness, and vomiting compared to MDMA alone. Co-intoxication with other substances increases odds of bradycardia, psychosis, and coma. Mortality rates remain low across all groups. Female patients report less chest pain but more vomiting, headache, and hypotension than males. These variations suggest that physicians should consider both the type of co-intoxication and patient sex to optimize treatment.